<DOC>
	<DOCNO>NCT02781246</DOCNO>
	<brief_summary>Dexmedetomidine prolong duration local anesthetic , effect perineural dexmedetomidine potency ropivacaine brachial plexus block pediatric patient investigate . This study design determine effect perineural dexmedetomidine ropivacaine brachial plexus block pediatric patient</brief_summary>
	<brief_title>Effect Perineural Dexmedetomidine ED50 Ropivacaine Brachial Plexus Blocks Pediatric Patients : Randomized Trial</brief_title>
	<detailed_description>150 child schedule arm forearm surgery underwent supraclavicle brachial plexus block ropivacaine guide ultrasound visualisation randomly assign one five group : Group A ( perineural ropivacaine ) , Group B ( ropivacaine plus 0.5 mcg/kg dexmedetomidine ) , Group C ( ropivacaine plus 1 mcg/kg dexmedetomidine ) , Group D ( ropivacaine plus 1.5mcg/kg dexmedetomidine ) Group E ( ropivacaine plus 2 mcg/kg dexmedetomidine ) . The primary endpoint minimum local anesthetic concentration ( MLAC ) , determine use Dixon up-and-down method . The secondary endpoint duration analgesia sedation</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>ASA I , II child , age 2 6 year , schedule arm forearm surgery underwent supraclavicular brachial plexus block . subject neurological , neuromuscular , psychiatric , blood clotting disorder , know history active severe renal , hepatic , respiratory , cardiac disease , know allergy systemic local anesthetic dexmedetomidine</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>